Pliant Therapeutics, Inc. · GETTEX:9PT

Pliant Therapeutics, Inc. financial statements

Pliant Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue001.58M9.69M7.57M41.8M57.1M0
Cost of revenue1.70M2.13M1.84M3.68M3.20M666.0K
Gross profit-1.70M-2.13M1.58M9.69M7.57M41.8M57.1M-666.0K
Research and development109.2M169.3M127.8M96.9M77.5M66.2M47.4M24.4M14.5M
Selling, general and administrative47.2M59.1M57.9M39.9M27.6M17.3M10.9M6.50M3.82M
Operating income-156.4M-228.4M-184.1M-127.2M-97.5M-41.6M-1.23M-30.9M-18.3M
Depreciation and amortization1.70M2.13M1.84M1.82M1.53M1.31M1.11M666.0K292.0K
EBITDA-154.7M-226.2M-182.3M-125.4M-96.0M-40.3M-118.0K-30.2M-18.1M
Interest expense2.56M3.02M1.27M791.0K0366.0K216.0K00
Income before tax-149.3M-210.3M-161.3M-123.3M-97.3M41.5M600.0K-30.3M-18.3M
Income tax0000000639.0K2.29M
Net income-149.3M-210.3M-161.3M-123.3M-97.3M-41.5M-631.0K-30.3M-20.6M
Earnings per share, basic-2.43-3.47-2.75-2.94-2.71-1.95-4.22-1.83-25.67
Earnings per share, diluted-2.43-3.47-2.75-2.94-2.71-1.95-4.22

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents45.4M71.2M63.2M33.7M51.7M50.9M85.8M60.9M4.25M
Short-term investments145.5M284.5M431.0M297.5M148.9M226.0M17.0M0
Receivables823.0K2.30M01.98M2.00M9.28M7.05M500.0K250.0K
Inventory11
Current assets196.4M362.3M505.5M340.3M209.4M290.8M111.9M61.7M4.71M
Property, plant and equipment2.94M5.53M3.57M4.49M4.61M4.32M4.08M4.26M1.85M
Total assets225.2M396.9M512.2M350.6M221.2M295.5M119.1M66.5M6.55M
Accounts payable480.0K5.96M4.53M1.58M2.97M2.02M1.25M2.58M1.59M
Current liabilities16.4M33.2M28.5M23.9M16.8M11.6M8.17M5.08M3.19M
Long-term debt30.2M10.1M9.93M
Total debt030.2M10.1M9.93M0283.0K444.0K525.0K
Total liabilities44.0M92.9M38.6M37.3M22.2M12.5M9.08M67.4M3.19M
Shareholders' equity181.2M304.1M473.6M313.3M199.1M283.1M-76.3M-882.0K3.35M
Shares outstanding61.4M60.9M59.9M48.9M36.1M35.6M1.85M16.5M803.5K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-128.3M-155.5M-116.4M-94.6M-75.4M-37.3M-2.75M-28.3M-16.9M
Capital spending-374.0K-3.85M-921.0K-1.76M-1.95M-1.53M-964.0K-2.32M-1.41M
Free cash flow-128.7M-159.4M-117.3M-96.4M-77.4M-38.8M-3.71M-30.7M-18.3M
Cash from investing134.3M140.3M-127.0M-150.2M73.7M-210.9M-17.9M-2.32M-1.41M
Cash from financing-31.7M23.1M274.4M226.9M2.53M213.2M45.5M87.3M20.0M
Share buybacks215.6M2.53M213.2M48.1M87.3M-12.0K
Change in cash-25.7M7.95M31.0M-18.0M783.0K-34.9M24.9M56.7M1.68M